- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01555645
Stress Management in Breast Cancer Patients
How Can Health Care Help Female Breastcancer Patients Reduce Their Stress Symptoms? A Randomized Intervention Study With Stepped-care
The purpose of this study within Caring sciences is to identify women with breast cancer who have stress symptoms and to offer these women appropriate care to reduce stress and increase well-being. This will be achieved by
- Studying the prevalence of stress related symptoms in female patients with breast cancer
- Testing the use of two short screening instruments to identify women at risk for developing long-standing stress symptoms
- Studying the level and intensity of stress management interventions required to achieve increased well-being, using a stepped-care approach.
- Studying the effects of interventions based on cognitive behavior therapy, delivered individually or in a group format.
The hypothesis is that half of the individuals assigned to a low intensity intervention will be significantly improved after treatment. For individuals who continue to have symptoms after low intensity treatment it is hypothesized that continued treatment in a group setting with high intensity interventions will be more cost-effective. In addition the assumption is that reduction of stress symptoms in women with breast cancer will lead to a reduction in socio-economic costs.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Falun, Sweden
-
Gävle, Sweden
-
Uppsala, Sweden
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- over the age of 18
- a recent diagnosis of breast cancer
- scheduled for adjuvant treatment in Falun, Gävle or Uppsala (Sweden)
Exclusion Criteria:
- ongoing psychiatric condition
- language deficiencies in Swedish
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Stress management Individual format
The methods and techniques will be the same as those used in the group intervention.
The first session will be used for a detailed assessment of the individual's psychosocial problems, as used in earlier studies.
The sessions will last 45 - 60 minutes.
The number of sessions will depend on the individual patient's problems and the joint assessment made by the patient and nurse together.
The total number of sessions will be at least 4, with a maximum of 8.
The contents of the sessions are Session 1: Assessment, Session 2: Analysis of diary (self-registration) and suggestions for problem management, Session 3: Evaluation of problem management skills Session 4: Follow-up and conclusion of the intervention.
When necessary Sessions 5 -8 will address specific obstacles and continued practice.
|
All patients start at the first step of the intervention program with a two hours psychoeducation in stress management.
Patients, who don't report a decrease in stress related symptoms, after the first step will be offered an intensive stress management, either in individual or group format.
Components included in the intervention concern 1) basic knowledge about cancer, treatment, healthy living and stress reactions, 2) self-awareness with help of diary for thoughts, feelings and behavior 3) instruction in various techniques on how to express negative feelings, how to communicate with others more effectively, how to change behaviors related to stress 4) training these techniques in real-life situations 5) cognitive restructuring 6) spirituality, derived from cognitive behavior therapy.
|
|
Experimental: Stress management Group format
Participants will meet for 2 hours every week for a total of 20 hours.
In the intervals between the group meetings patients will be asked to do homework.
Homework entails practicing problem-solving techniques, keeping a diary, practicing relaxation or physical activities.
Each group meeting has a specific subject, i.e.
What is stress and stress behaviors, Stress related symptoms, How to manage anger and negative thoughts, Self-registrations and behavioral changes, Future perspectives, Cancer, stress and relations, Expectations and demands, Body, pleasure and sexuality.
|
All patients start at the first step of the intervention program with a two hours psychoeducation in stress management.
Patients, who don't report a decrease in stress related symptoms, after the first step will be offered an intensive stress management, either in individual or group format.
Components included in the intervention concern 1) basic knowledge about cancer, treatment, healthy living and stress reactions, 2) self-awareness with help of diary for thoughts, feelings and behavior 3) instruction in various techniques on how to express negative feelings, how to communicate with others more effectively, how to change behaviors related to stress 4) training these techniques in real-life situations 5) cognitive restructuring 6) spirituality, derived from cognitive behavior therapy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Psychosocial aspect
Time Frame: Changes in psychosocial aspects from baseline to 12 months post diagnosis
|
Intrusion, Avoidance, Anxiety, Depression, Quality of life, Fatigue, Daily stress
|
Changes in psychosocial aspects from baseline to 12 months post diagnosis
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Cost-Utility Analysis
Time Frame: 12 month
|
12 month
|
|
Patient satisfaction
Time Frame: 3 month, after intensive intervention and 12 month
|
3 month, after intensive intervention and 12 month
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Karin Nordin, Prof, Uppsala University
Publications and helpful links
General Publications
- Hellerstedt-Borjesson S, Nordin K, Fjallskog ML, Holmstrom IK, Arving C. Women Treated for Breast Cancer Experiences of Chemotherapy-Induced Pain: Memories, Any Present Pain, and Future Reflections. Cancer Nurs. 2016 Nov/Dec;39(6):464-472. doi: 10.1097/NCC.0000000000000322.
- Nordin K, Rissanen R, Ahlgren J, Burell G, Fjallskog ML, Borjesson S, Arving C. Design of the study: how can health care help female breast cancer patients reduce their stress symptoms? A randomized intervention study with stepped-care. BMC Cancer. 2012 May 4;12:167. doi: 10.1186/1471-2407-12-167.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- K2010-70X-21412-01-3
- CAN 2009/25 (Other Grant/Funding Number: the Swedish Cancer Society)
- CAN 2011/08 (Other Grant/Funding Number: the Swedish Cancer Society)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer
-
Baylor Breast Care CenterRecruitingBreast Cancer | Breast Neoplasm | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Estrogen Receptor-positive Breast Cancer | Hormone Receptor-positive Breast Cancer | Breast Cancer InvasiveUnited States
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedInflammatory Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast CancerUnited States
-
University of Colorado, DenverCompletedStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
National Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerCanada
-
Mayo ClinicMarker Therapeutics, Inc.CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
University of Central FloridaFlorida Department of HealthRecruitingBreast Cancer | Breast Cancer Female | Breast Cancer Diagnosis | Breast Cancer Survivors | Breast Cancer Detection | Breast Cancer AwarenessUnited States
Clinical Trials on Stress management, in two steps
-
University of PittsburghCenters for Disease Control and PreventionCompletedDistorted; Balance | Lower Extremity Weakness DistalUnited States
-
University of MichiganNational Institute on Aging (NIA); Henry Ford Health SystemCompletedChronic PainUnited States
-
University of MichiganNational Institute on Aging (NIA); American Pain SocietyCompletedChronic PainUnited States
-
University Hospital, GrenobleFondation de FranceEnrolling by invitationBurnout, CaregiverFrance
-
ISA Associates, Inc.National Institute on Minority Health and Health Disparities (NIMHD)RecruitingHypertensionUnited States
-
Seattle Children's HospitalCompletedSarcoma | Lymphoma | Cancer | Acute Lymphoblastic Leukemia | Acute Myelogenous Leukemia | Brain Tumors | Germ Cell TumorUnited States
-
University of WashingtonNational Institute on Minority Health and Health Disparities (NIMHD)CompletedCommunication | Chronic Illness | Discrimination, Racial | Bias, RacialUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Baylor College of Medicine; Seattle Children... and other collaboratorsCompletedDepression | Quality of Life | Cancer | Anxiety | Communication | Coping Skills | HopeUnited States
-
Seattle Children's HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Seattle Children's HospitalCompleted